Alexander Tin
Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers stories related to public health agencies and infectious disease outbreaks, with a focus on the federal response to these issues. Prior to his current role, Tin worked as a campaign reporter for CBS News in Las Vegas and has experience working on 'Face the Nation' and the 'CBS Evening News'. Tin graduated from Columbia University in 2017 with a bachelor's degree in political science.
Biography:
https://www.cbsnews.com/team/alexander-tin/
96%
The Daily's Verdict
This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.
Bias
98%
Examples:
- Reported on multiple instances of contaminated products and outbreaks with a bias towards sensationalizing the risks involved.
- Used strong language to describe the severity of illnesses caused by these contaminated products.
Conflicts of Interest
100%
Examples:
- Covered stories related to the FDA and CDC, which could potentially create conflicts of interest due to their regulatory roles.
- Worked for CBS News, which may have a financial interest in reporting on certain topics or controversies related to food safety and public health.
Contradictions
80%
Examples:
- Provided contradictory statements regarding the status of recalls and ongoing investigations.
- Reported conflicting information about the extent and cause of outbreaks related to certain products.
Deceptions
90%
Examples:
- Presented information in a way that could be confusing or deceptive to readers.
- Used misleading language or omitted important context in some reports.
Recent Articles
FDA Investigates Diamond Shruumz Edibles: At Least 69 People Hospitalized After Consuming Psilocin-Laced Products
Broke On: Thursday, 18 July 2024The FDA is investigating Diamond Shruumz brand microdosing edibles after reports of illnesses and hospitalizations linked to the products, which contain psilocin, a hallucinogenic substance. At least 69 people have fallen ill with symptoms including seizures, confusion, and agitation. The FDA advises consumers not to purchase or consume Diamond Shruumz products and is monitoring the recall process initiated by Prophet Premium Blends. Consumers cannot rely on product labels as no one is currently regulating these products. 
CDC Reports Surge in Covid-19 Infections: High Viral Activity Levels in Wastewater Nationwide
Broke On: Monday, 15 July 2024CDC reports significant increase in Covid-19 emergency department visits and high viral activity levels nationwide, indicating a summer wave of infections. California and Los Angeles County experience notable jumps in cases, hospitalizations, and wastewater data. 
CDC Warns of COVID-19 Surge in 45 States: Prevalence of Contagious Variants and Rising Hospitalizations
Broke On: Monday, 15 July 2024CDC reports COVID-19 cases growing in 45 states, with high prevalence in the West. Over 70% of new infections are from contagious KP variants. Hospitalizations remain low but pose risks to vulnerable populations as summer surge continues and vaccines become outdated. 
Summer 2024: Record COVID-19 Surge in ER Patients and New Variants in Florida and Western States
Broke On: Monday, 03 June 2024CDC reports a summer surge in COVID-19 cases, hospitalizations, and deaths in the US. Florida sees one of the highest increases in emergency room patients with COVID-19. Two new variants, KP.3 and LB.1, contribute to this trend. Summer 2024: Record COVID-19 Surge in ER Patients and New Variants in Florida and Western States
Broke On: Monday, 03 June 2024CDC reports a summer surge in COVID-19 cases, hospitalizations, and deaths in the US. Florida sees one of the highest increases in emergency room patients with COVID-19. Two new variants, KP.3 and LB.1, contribute to this trend. 
Anaerobic Bacteria in Commercial Tattoo Inks: A First Report on Hidden Contamination
Broke On: Tuesday, 02 July 2024A recent study discovered that 35% of tattoo inks sold in the US are contaminated with bacteria, including anaerobic strains. This alarming finding emphasizes the need for monitoring these products to ensure microbial safety and prevent potential health risks such as rashes, lesions, and scarring. 
FDA Approves New Alzheimer's Treatment: Donanemab Slows Cognitive Decline
Broke On: Tuesday, 02 July 2024The FDA approves Eli Lilly's donanemab, a monoclonal antibody treatment for early symptomatic Alzheimer's disease that helps remove amyloid plaque buildup in the brain and significantly slows cognitive decline. The drug, sold as Kisunla, costs $12,522 for six months or about $32,000 yearly. 
Rising COVID-19 Cases in Western US: New Variants KP.2 and KP.3, LB.1 Concern; Updated Vaccines Offer Hope
Broke On: Monday, 01 July 2024COVID-19 cases and deaths have surged in the US, particularly in western states, due to new variants like KP.2 and KP.3. Wastewater surveillance systems show high levels of COVID-19 in sewage samples, indicating significant viral activity. The LB.1 variant is also a concern, making up over 30% of cases in the New York and New Jersey region and potentially being more contagious than previous strains. Vaccines remain effective against COVID-19, with updated vaccines targeting KP.2 expected later this year. H5N1 Bird Flu Survives in Raw Milk: How Pasteurization Prevents Potential Spread to Humans
Broke On: Saturday, 29 June 2024A recent study reveals that H5N1 bird flu can survive in raw milk for over an hour, raising concerns about its potential spread through contaminated dairy products. However, pasteurization effectively kills the virus in milk. The USDA warns against consuming unpasteurized dairy products due to the risk of infection and advises farmers to take preventative measures. 
New COVID-19 Subvariants KP.3, KP.2, and LB.1: Evading the Immune System and Surge in Cases During Summer Months
Broke On: Wednesday, 26 June 2024New COVID-19 subvariants KP.3, KP.2, and LB.1 are on the rise during summer months, causing an increase in cases due to their ability to evade the immune system effectively. Vulnerable populations are at higher risk for severe disease but vaccination remains the best defense against infection and severe illness as new vaccine formulations targeting these subvariants become available this fall.